By: Zosia Chustecka August 18, 2009 — The benefit of vaccinating against human papilloma virus (HPV) to prevent cervical cancer is questioned in an editorial in the Journal of the American Medical Association. “The theory behind the vaccine is sound: if HPV infection can be prevented, cancer will not occur,” writes editorialist Charlotte Haug, MD, […]
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18
Sholom Wacholder, study statistician and principal investigator1, Bingshu Eric Chen, assistant professor2, Allen Wilcox, senior investigator3, George Macones, professor of obstetrics and gynaecology4, Paula Gonzalez, study co-investigator5, Brian Befano, senior programmer6, Allan Hildesheim, study investigator, principal investigator1, Ana Cecilia Rodríguez, study co-investigator5, Diane Solomon, study co-investigator7, Rolando Herrero, study principal investigator5, Mark Schiffman, study co-investigator, […]
Cervarix Information for the User
Read all of this leaflet carefully before you start receiving this vaccine. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or pharmacist. – This medicine has been prescribed for you. Do not pass it on to others. – If any of the […]
Cervarix Warnings and Precautions
CONTRAINDICATIONS Severe allergic reactions (e.g., anaphylaxis) to any component of CERVARIX. WARNINGS AND PRECAUTIONS Syncope Because vaccinees may develop syncope, sometimes resulting in falling with injury, observation for 15 minutes after administration is recommended. Syncope, sometimes associated with tonic-clonic movements and other seizure-like activity, has been reported following vaccination with CERVARIX. When syncope is associated […]
Cervarix, European Public Assessment Report
Authorisation details Product information Assessment history Read reports here.
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- Next Page »